BioSpace News Archive

IZI Medical Products, LLC (“IZI”), a leading manufacturer of interventional radiology devices, announces that it has received CE Mark approval in Europe for the KivaTM Vertebral Compression Fracture (VCF) Treatment System.

Thinking differently about thinking – Development plans for SAGE-718 focused on executive function across multiple indications Early learnings from studies of other compounds created multi-faceted insights for SAGE-324 program in essential tremor Interview with investigator from SHORELINE study highlights potential for multiple approaches in the treatment of MDD Additional details about Phase 3 trial with brexanolone in COVID-19 related

Merck to Present at the Morgan Stanley 18th Annual Virtual Global Healthcare Conference ,

Selvita (WSE: SLV), one of the largest preclinical contract research organizations in Europe , reported today its H1 2020 financial results and provided a corporate update. For the H1 2020, Selvita reports consolidated revenues of EUR 15.2 million , up by 47% on a year-on-year basis. The EBITDA result reached EUR 3.6 mil

Matinas BioPharma Holdings, Inc. (NYSE AMER: MTNB), today announced that Jerome D. Jabbour, Chief Executive Officer, has been invited to participate on a panel of top innovators in anti-infective drug development as part of Maxim Group’s M-VEST Virtual Conference Series. Date: Thursday, September 17, 2020 Panel details: A discussion among CEOs of top anti-fungal innovators, moderated by Maxim Group analyst, Jason McCarthy, Ph.D. Time

MISSISSAUGA, Ontario, Sept. 10, 2020 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. (TSX: MBX, OTCQB: MBXBF, Microbix ® ), an award-winning life sciences innovator and exporter, is pleased to announce attainment of Australian Therapeutic Goods Administration (TGA) registration for its COVID-19 and high-risk HPV quality assessment products (QAPs™) – TGA registration of these REDx™ Controls & REDx™FLOQ ® products by Microbix’s distributor, R-Biopharm, enables it to offer these workflow contro

EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT), a pharmaceutical company committed to developing and commercializing innovative ophthalmic products, today announced that Nancy Lurker, President and Chief Executive Officer, will present in two upcoming virtual conferences in September. Cantor Virtual Healthcare Conference Date: Tuesday, September 15 Time: 4:40 PM Eastern Time H.C. Wainwright 22nd Annual Global Investment Conference Date

Myriad Genetics, Inc. (NASDAQ: MYGN, “Myriad” or the “Company”), a global leader in molecular diagnostics and precision medicine, today announced the election of Rashmi Kumar, age 51, to its Board of Directors, effective immediately, expanding the Board to 12 members. Additionally, Ms. Kumar was appointed to the Audit and Finance Committee of Myriad’s Board. Ms. Kumar is Senior Vice President and Global Chief Information Officer of Hewlett

Athenex, Inc. (Nasdaq: ATNX), a global biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies for the treatment of cancer, today announced the pricing of a public offering of 10,000,000 shares of its common stock at a public offering price of $11.00 per share. The gross proceeds to Athenex from the offering, before underwriting discounts and commissions and estimated offering expenses, are exp

Transparency Market Research has published a new report titled, ‘Global Swab and Viral Transport Medium Market ’.